243 related articles for article (PubMed ID: 31734909)
1. Cerebrospinal fluid total protein in Guillain-Barré syndrome variants: correlations with clinical category, severity, and electrophysiology.
Bourque PR; Brooks J; Warman-Chardon J; Breiner A
J Neurol; 2020 Mar; 267(3):746-751. PubMed ID: 31734909
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid analysis in Guillain-Barré syndrome: value of albumin quotients.
Rath J; Zulehner G; Schober B; Grisold A; Krenn M; Cetin H; Zimprich F
J Neurol; 2021 Sep; 268(9):3294-3300. PubMed ID: 33651153
[TBL] [Abstract][Full Text] [Related]
3. Age matters: Impact of data-driven CSF protein upper reference limits in Guillain-Barré syndrome.
Bourque PR; Brooks J; McCudden CR; Warman-Chardon J; Breiner A
Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e576. PubMed ID: 31355312
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid findings in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathies.
Illes Z; Blaabjerg M
Handb Clin Neurol; 2017; 146():125-138. PubMed ID: 29110767
[TBL] [Abstract][Full Text] [Related]
5. Association of CSF Total Protein with Clinical Heterogeneity, Disease Severity and Electrophysiological Pattern in GBS Patients.
Rahaman H; Rahman HZ; Emran MM; Rahman MA
Mymensingh Med J; 2024 Apr; 33(2):496-500. PubMed ID: 38557532
[TBL] [Abstract][Full Text] [Related]
6. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.
Notturno F; Kokubun N; Sekiguki Y; Nagashima T; De Lauretis A; Yuki N; Kuwabara S; Uncini A
J Neurol Sci; 2016 Jun; 365():132-6. PubMed ID: 27206890
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of Guillain-Barré syndrome and validation of the Brighton criteria in Malaysia.
Tan CY; Razali SNO; Goh KJ; Shahrizaila N
J Peripher Nerv Syst; 2020 Sep; 25(3):256-264. PubMed ID: 32511817
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Cerebrospinal Fluid Protein Levels and Electrophysiologic Abnormalities in Guillain-Barré Syndrome.
DiCapua DB; Lakraj AA; Nowak RJ; Robeson K; Goldstein J; Patwa H
J Clin Neuromuscul Dis; 2015 Dec; 17(2):47-51. PubMed ID: 26583489
[TBL] [Abstract][Full Text] [Related]
9. Elevated blood and cerebrospinal fluid glucose levels affect the severity and short-term prognosis of Guillain-Barré syndrome.
Gong Q; Liu S; Xiao Z; Fu X; Lu Z
Neurol Res; 2022 Feb; 44(2):121-127. PubMed ID: 34382919
[TBL] [Abstract][Full Text] [Related]
10. CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome.
Al-Hakem H; Doets AY; Stino AM; Zivkovic SA; Andersen H; Willison HJ; Cornblath DR; Gorson KC; Islam Z; Mohammad QD; Sindrup SH; Kusunoki S; Davidson A; Casasnovas C; Bateman K; Miller JAL; van den Berg B; Verboon C; Roodbol J; Leonhard SE; Arends S; Luijten LWG; Benedetti L; Kuwabara S; Van den Bergh P; Monges S; Marfia GA; Shahrizaila N; Galassi G; Pereon Y; Bürmann J; Kuitwaard K; Kleyweg RP; Marchesoni C; Sedano Tous MJ; Querol L; Martín-Aguilar L; Wang Y; Nobile-Orazio E; Rinaldi S; Schenone A; Pardo J; Vermeij FH; Waheed W; Lehmann HC; Granit V; Stein B; Cavaletti G; Gutiérrez-Gutiérrez G; Barroso FA; Visser LH; Katzberg HD; Dardiotis E; Attarian S; van der Kooi AJ; Eftimov F; Wirtz PW; Samijn JPA; Gilhuis HJ; Hadden RDM; Holt JKL; Sheikh KA; Kolb N; Karafiath S; Vytopil M; Antonini G; Feasby TE; Faber C; Kramers H; Busby M; Roberts RC; Silvestri NJ; Fazio R; van Dijk GW; Garssen MPJ; Verschuuren J; Harbo T; Jacobs BC;
Neurology; 2023 Jun; 100(23):e2386-e2397. PubMed ID: 37076309
[TBL] [Abstract][Full Text] [Related]
11. Study on Electrophysiological Findings of Guillain Barre Syndrome Patients Attending the Department of Neurology in BSMMU.
Das S; Khan RK; Alam SM; Chowdhury NH; Das P
Mymensingh Med J; 2018 Jul; 27(3):631-640. PubMed ID: 30141456
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
Wang XK; Zhang HL; Meng FH; Chang M; Wang YZ; Jin T; Mix E; Zhu J
Neurol Sci; 2013 May; 34(5):655-61. PubMed ID: 22526766
[TBL] [Abstract][Full Text] [Related]
13. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome.
Umapathi T; Li Z; Verma K; Yuki N
Clin Neurophysiol; 2015 Dec; 126(12):2376-80. PubMed ID: 25743269
[TBL] [Abstract][Full Text] [Related]
14. A unicenter, prospective study of Guillain-Barré syndrome in Spain.
Sedano MJ; Orizaola P; Gallardo E; García A; Pelayo-Negro AL; Sánchez-Juan P; Infante J; Berciano J
Acta Neurol Scand; 2019 Jun; 139(6):546-554. PubMed ID: 30929269
[TBL] [Abstract][Full Text] [Related]
15. Guillain-Barré syndrome subtypes: A clinical electrophysiological study of 100 patients.
Grapperon AM; Berro M; Salort-Campana E; Verschueren A; Delmont E; Attarian S
Rev Neurol (Paris); 2019; 175(1-2):73-80. PubMed ID: 30442448
[TBL] [Abstract][Full Text] [Related]
16. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
17. Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes.
Wong AH; Umapathi T; Nishimoto Y; Wang YZ; Chan YC; Yuki N
J Peripher Nerv Syst; 2015 Mar; 20(1):47-51. PubMed ID: 25640907
[TBL] [Abstract][Full Text] [Related]
18. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain-Barré syndrome.
Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS
J Neurol Sci; 2014 May; 340(1-2):37-43. PubMed ID: 24607336
[TBL] [Abstract][Full Text] [Related]
19. Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.
Berciano J; Sedano MJ; Pelayo-Negro AL; García A; Orizaola P; Gallardo E; Lafarga M; Berciano MT; Jacobs BC
J Neurol; 2017 Feb; 264(2):221-236. PubMed ID: 27314967
[TBL] [Abstract][Full Text] [Related]
20. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
